Skip to content

The Effect of Dexmedetomidine Hydrochloride Nasal Spray on Pain in Patients Undergoing Percutaneous Transforaminal Endoscopic Spine Surgery: A Prospective, Double-Blind, Randomized Controlled Trial

The Effect of Dexmedetomidine Hydrochloride Nasal Spray on Pain in Patients Undergoing Percutaneous Transforaminal Endoscopic Spine Surgery: A Prospective, Double-Blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128250
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-22
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Group C:Patients were given 2ug/kg dexmedetomidine hydrochloride nasal spray
Group A:Nasal spray of physiological saline solution
Group B:Patients were given 1ug/kg dexmedetomidine hydrochloride nasal spray

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Patients who have failed conservative treatment and are scheduled to undergo intervertebral foramen endoscopy; 3. ASA?~?; 4. The patient is informed and signs their consent for this study.

Exclusion criteria

Exclusion criteria: 1. Patients not suitable for nasal spray administration or unwilling to accept nasal administration; 2. Individuals allergic to any medication used in this experiment; 3. Patients with systolic blood pressure 140 mmHg and diastolic blood pressure 90 mmHg; 4. Patients with heart rate (HR) 100 bpm; 5. Individuals with a history of allergic rhinitis, nasal surgery, and respiratory infections within the past 2 weeks; 6. Patients with severe cardiovascular and cerebrovascular abnormalities as well as liver and kidney dysfunction before surgery; 7. Patients who have been regularly taking other analgesics (such as opioids) recently; 8. Hearing impairment, language comprehension impairment, mental illness, etc.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale score;

Secondary

MeasureTime frame
Richmond Agitation-Sedation Scale rating;blood pressure;Pulse oxygen saturation;heart rate;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactLinlin Zhao

The Affiliated Hospital of Xuzhou Medical University

Lin1675@163.com+86 18168777313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026